People channel feed – Endpoints News

People channel feed

Lonnie Moulder woos a seasoned development expert from Hillhouse's US/China play to helm his startup

5 years ago

Stealthy Third Rock startup poaches oncology exec from Novartis — just days after his boss jumped ship

5 years ago

Alkermes hands a board seat to Alex Denner's Sarissa after facing renewed proxy pressure to 'refresh' directors

5 years ago

Bobbing on a sea of crises, bluebird's Nick Leschly sees his pay cut in half as the biotech prepares to split

5 years ago

Stanley Erck bagged $48M in pay as he guided Novavax on a remarkable turnaround in the hunt for a Covid-19 vaccine

5 years ago

Biogen's Michel Vounatsos takes home $18.7M in pay as the company battles to take aducanumab to market

5 years ago

Regeneron's Len Schleifer, George Yancopoulos start their ambitious 5-year plan, earning a front-loaded $270M combined

5 years ago

Exclusive: Ultimate biotech insider Dan Lynch takes his 30 years of experience to GV to fill a newly-created post

5 years ago

Early Zymergen investor Jenny Rooke reflects on 'chimeras' in biotech, what it takes to spot a $500M gem

5 years ago

Teva CEO Kåre Schultz sees a 35% raise despite the company's continued legal woes

5 years ago

Exclusive: Genentech's former Tecentriq 'CEO' jumps ship to head up commercial at an oncolytic virus player

5 years ago

MIT’s fabled billionaire scientist Robert Langer is stepping in to offer a key assist to Ovid CEO Jeremy Levin

5 years ago

Jami Rubin, once fabled for grilling biopharma execs, decamps to head finance at drug pricing disrupter

5 years ago

The doctor is in: Trump insider Ben Carson joins NASH player Galectin as a 'special consultant,' part-time spokesman

5 years ago

Eli Lilly-partnered biotech taps star investigator Alan List as CMO — a year after he resigned from Moffitt over China scandal

5 years ago

GlaxoSmithKline’s head of vaccine R&D is jumping to a wellness company concentrating on the microbiome as reports of an exodus start to spread

5 years ago

Eli Lilly axes 163 Dermira staffers, shutters Menlo Park site as it closes in around Dupixent rival lebrikizumab

5 years ago

The right to vote is fundamental — a letter from biotechnology industry leaders

5 years ago

Former head of FDA’s medical and scientific affairs on Covid: ‘FDA has never been tested like this’

5 years ago

Pankaj Bhargava was a central figure in the group fashioning Gilead’s oncology strategy. Now he’s jumped to the VC side and the next-gen game at Dana-Farber

5 years ago

Amarin CEO John Thero passes baton to Europe commercial chief as M&A hopes continue to deflate

5 years ago

Patrizia Cavazzoni named permanent director of CDER, adding to questions around where Woodcock will end up

5 years ago

The numbers are in, and new Vertex CEO Reshma Kewalramani took home half of what predecessor Jeff Leiden did in his last year on the job

5 years ago

Can he pick them? A high-profile Wall Street analyst jumps into biotech as CFO of an oncology upstart

5 years ago

First page Previous page 58 59 606162 63 64 Next page Last page